Urologie und Urogynäkologie 5 Min NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme Laborie welcomed the inclusion of Optilume® Urethral Drug-Coated Balloon (DCB)... Geschrieben von Laborie
Urologie und Urogynäkologie 3 Min Laborie Unveils Positive Study Results for Optilume® BPH Catheter System Laborie announced positive 2-year and 5-year results from studies for... Geschrieben von Laborie
Unkategorisiert | Urologie und Urogynäkologie 3 Min Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association Laborie Medical Technologies Corp (Laborie), announced today that the American... Geschrieben von Laborie
Urologie und Urogynäkologie 3 Min Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and... Geschrieben von Laborie
Urologie und Urogynäkologie 4 Min Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic... Geschrieben von Laborie
Urologie und Urogynäkologie 4 Min Laborie’s Optilume® Drug-Coated Balloon for Stricture Secures Coverage from BCBS of Michigan Effective July 1, 2025, Blue Cross Blue Shield of Michigan... Geschrieben von Laborie
